Nobel Biocare Holding AG - SWOT Analysis
| Publication Date | October 2008 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 26 |
| ISBN Number | not applicable |
| Product Code | DAT05663 |
Summary
Datamonitor's Nobel Biocare Holding AG *SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Nobel Biocare Holding (Nobel Biocare), a medical devices company, manufactures and markets esthetic dental solutions such as dental implants, customized dental prosthetics and a complete set of restorative components for lost teeth. The company primarily operates in Europe and North America. The company is headquartered in Zurich, Switzerland and employs about 2,200 people. The company recorded revenues of E665.9 million (approximately $912.7 million) during the financial year (FY) ended December 2007, an increase of 10.9% over 2006. The operating profit of the company was E216.7 million (approximately $297.1 million) during FY2007, an increase of 6.1% over 2006. The net profit was E166.2 million (approximately $227.8 million) in FY2007, an increase of 5.1% over 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers businesses better
*Qualify prospective partners and suppliers
- Keep fully up to date on your competitors business structure, strategy and prospects
- Obtain the most up to date company information available
This report covers the following industry codes:
SIC Code: 3843
NAICS Code: 339114
Content
- This Product Typically Includes The Following Sections:
- Key Facts
- Company Overview
- Business Description
- Company History
- Key Employees
- Key Employee Biographies
- Company View
- Swot Analysis
- Products & Services Listing
- Products & Services Analysis
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















